UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

What is a clinically meaningful change in exhaled nitric oxide for children with asthma?

Fielding, S; Pijenburg, M; de Jongste, J; Pike, K; Roberts, G; Petsky, H; Chang, A; ... Turner, S; + view all (2020) What is a clinically meaningful change in exhaled nitric oxide for children with asthma? Pediatric Pulmonology , 55 (3) pp. 599-606. 10.1002/ppul.24630. Green open access

[thumbnail of As resubmitted to Ped Pul.pdf]
Preview
Text
As resubmitted to Ped Pul.pdf - Accepted Version
Available under License : See the attached licence file.

Download (376kB) | Preview

Abstract

Introduction: Fractional exhaled nitric oxide (FENO) may be a useful objective measurement to guide asthma treatment. What remains uncertain is what change in FENO is clinically significant. Methods: An individual patient data analysis was performed using data from seven randomized clinical trials which used FENO to guide asthma treatment. The absolute and percentage intra‐subject change in FENO measurements over “stable” and also “unstable” 3‐month periods were described. Results: Data were available in 1112 randomized controlled trial participants and ≥1 stable period was present for 665 individuals. The interquartile range (IQR) and limits of agreement (LoA) for change in absolute FENO among individuals whose initial FENO was <50 parts per billion (ppb) were −7 to +9 ppb and −43 to +50 ppb, and for those with initial FENO ≥50 ppb IQR was −29 to +17 ppb and LoA was −80 to +76 ppb. For percentage change in FENO, the IQR and LoA for individuals whose initial FENO was <50 ppb were −33% to +51% and −157% to +215%, and for those with initial FENO ≥50 ppb were −33% to +35% and −159% to +192%. The variation in FENO values for a stable period was similar irrespective of whether it was followed by a stable or unstable period. Conclusions: Over a 3‐month period where FENO is initially <50 ppb, a rise of <10 ppb or of <50% (based on IQR) is unlikely to be related to asthma. When FENO is initially ≥50 ppb an percentage change of <50% (based on IQR) is unlikely to be asthma‐related.

Type: Article
Title: What is a clinically meaningful change in exhaled nitric oxide for children with asthma?
Open access status: An open access version is available from UCL Discovery
DOI: 10.1002/ppul.24630
Publisher version: https://doi.org/10.1002/ppul.24630
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Infection, Immunity and Inflammation Dept
URI: https://discovery.ucl.ac.uk/id/eprint/10088533
Downloads since deposit
38Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item